| Name | Title | Contact Details |
|---|
DePuy Mitek is a Raynham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Collington is a Life Care community with so many advantages. We are committed to providing residents with a holistic approach to personal health, wellness and physical well-being. Inspired by the abundance of natural, intellectual and social interaction, Collington provides an active lifestyle of choice, independence and a true sense of community. Here you will be close to the shopping, restaurants and social activities that you are used to being a part of, as well as living in a welcoming, quiet and relaxing home. Collington is ideally situated in close proximity to Washington D.C., Baltimore`s Inner Harbor, Historic Annapolis and the new National Harbor-so you can stay connected to the events and opportunities that interest you, excite you and inspire you. Located on 125 beautifully serene acres, Collington is known for its peaceful campus featuring native trees, rolling lawns, a six-acre lake, walking trails and exquisite gardens. All of this makes for a tranquil surrounding, helping to slow down the pace of everyday life and providing opportunity to enjoy the nature around you. The community features an exceptional selection of apartments and cottages and assures unlimited access to a full continuum of on-site health care services, should you ever need it. Collington is full of international, diverse and active residents involved in pursuing new opportunities in retirement. This stimulating environment is where you will find it easy to get involved with neighbors who share your passion for life! Most retirement communities offer access to health care should you ever need it-with little assurance about cost or availability of care. By contrast, Collington assures its Life Care residents unlimited access to nursing care-including assisted living, recuperative care, memory care and long-term care if needed. This is the true value of Life Care.
Advanced Health Education Center is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Peloton is the largest interactive fitness platform in the world with a loyal community of more than 2.6 million Members. The company pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its Members anytime, anywhere. Peloton makes fitness entertaining, approachable, effective, and convenient, while fostering social connections that encourage its Members to be the best versions of themselves. An innovator at the nexus of fitness, technology, and media, Peloton has reinvented the fitness industry by developing a first-of-its-kind subscription platform that seamlessly combines the best equipment, proprietary networked software, and world-class streaming digital fitness and wellness content, creating a product that its Members love. The brand`s immersive content is accessible through the Peloton Bike, Peloton Tread, and Peloton App, which allows access to a full slate of fitness classes across disciplines, on any iOS or Android device, Fire TV, Roku, Chromecast and Android TV. Founded in 2012 and headquartered in New York City, Peloton has a growing number of retail showrooms across the US, UK, Canada and Germany.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.